Pear Therapeutics wins FDA nod for digital opioid addiction treatment app

Pear Therapeutics has received FDA 510(k) clearance for its reSET-O medical application that helps treat patients who have an opioid use disorder.

The reSET-O app is a prescription cognitive behavioral therapy that is designed to be used with outpatient treatment and under the care of a healthcare professional. It is also designed to be used with a treatment that includes buprenorphine and contingency management.

Get the full story on our sister site, Medical Design & Outsourcing.

The post Pear Therapeutics wins FDA nod for digital opioid addiction treatment app appeared first on MassDevice.

from MassDevice https://ift.tt/2A5RzvV